about
Human telomerase and its regulationHuman survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathwayChondroprotection by urocortin involves blockade of the mechanosensitive ion channel Piezo1.T-lymphoblastic lymphoma cells express high levels of BCL2, S1P1, and ICAM1, leading to a blockade of tumor cell intravasation.PPAR gamma ligand-induced apoptosis through a p53-dependent mechanism in human gastric cancer cells.Actin polymerization negatively regulates p53 function by impairing its nuclear import in response to DNA damage.Mitogen-activated protein kinase activation in UV-induced signal transduction.p53 Enables metabolic fitness and self-renewal of nephron progenitor cellsGrowth inhibition and apoptotic effects of total flavonoids from Trollius chinensis on human breast cancer MCF-7 cells.Strategies for therapeutic targeting of the p53 pathway in cancer.Adaptive methylation regulation of p53 pathway in sympatric speciation of blind mole rats, SpalaxCombination of p53AIP1 and survivin expression is a powerful prognostic marker in non-small cell lung cancerPhase 2 randomized study of p53 antisense oligonucleotide (cenersen) plus idarubicin with or without cytarabine in refractory and relapsed acute myeloid leukemia.Cellular adaptation to hypoxia and p53 transcription regulation.A role for the p53 tumour suppressor in regulating the balance between homologous recombination and non-homologous end joining.Codon 104 variation of p53 gene provides adaptive apoptotic responses to extreme environments in mammals of the Tibet plateau.Liposomal nanomedicine for breast cancer therapy.Mutant p53 melanoma cell lines respond differently to CP-31398-induced apoptosis.Rapid caspase-dependent cell death in cultured human breast cancer cells induced by the polyamine analogue N(1),N(11)-diethylnorspermine.The regulation of telomerase in oncogenesis.Ovulation-induced DNA damage in ovarian surface epithelial cells of ewes: prospective regulatory mechanisms of repair/survival and apoptosis.Characterization of the p53-rescue drug CP-31398 in vitro and in living cells.Characterization of new-generation aminoglycoside promoting premature termination codon readthrough in cancer cells.
P2860
Q24533247-99D9B658-4C0F-42CA-AEA8-503640618AE5Q28215330-7E000757-364C-479E-B01F-6F4DBAE720FCQ33894945-06C1B2CF-1B20-4C11-A187-E7C505FA3852Q34412894-FE24E71E-BCEC-4C40-983C-327FA98D3F19Q34534825-798AC511-DA52-4C5F-A543-8E774EB513D2Q34658173-3DA4E49A-E7CF-494D-A33F-706783FFF27DQ35055502-D2167A1A-6B84-4765-B833-2F65E18A9428Q35228883-46462A9D-F51A-4DC0-870E-55C1AF04F84DQ36124925-8654B92C-04F7-4463-AB17-8B30B9AB960EQ36430162-DB71113D-0822-42D3-887D-8547D5F845E7Q36646327-5046847D-43C0-4E44-9BC7-2603ABBC636DQ37126082-08ACFAB2-73CA-49DD-98E1-657318A8D4DAQ37158722-F3EB187F-B493-4089-A66A-0450DC826F5EQ37177493-1589E424-2FA4-41A6-B05E-303DB68C9E31Q37299259-11135EA6-B80E-40F5-974D-355CA1982B36Q37409271-FEE28117-CC1F-4D03-B32C-7205436F5097Q37939968-B2C495A6-E9EB-48EC-A56D-FE89B253655EQ40362071-25253167-3829-42D9-BC66-C19FC1AF488EQ40750837-D4DDB9CC-B03C-4EC3-AB3E-72A65F84E7A3Q42152999-CA2899C1-BF75-42E6-A1CA-38F8260FE247Q43774838-3A1F1274-DF1D-47E6-B2D2-F68F56CB5791Q43955939-5E1E57B3-3748-4DDF-A21C-C80308FD8F07Q51158606-262B1770-FCB4-4A1E-9E21-B5D260139D93
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
p53-induced apoptosis as a safeguard against cancer.
@ast
p53-induced apoptosis as a safeguard against cancer.
@en
type
label
p53-induced apoptosis as a safeguard against cancer.
@ast
p53-induced apoptosis as a safeguard against cancer.
@en
prefLabel
p53-induced apoptosis as a safeguard against cancer.
@ast
p53-induced apoptosis as a safeguard against cancer.
@en
P356
P1476
p53-induced apoptosis as a safeguard against cancer
@en
P2093
P356
10.1006/BBRC.1999.1446
P407
P577
1999-11-01T00:00:00Z